Cross Country Healthcare Inc

Cross Country Healthcare Inc(CCRN)股票分析

$13.250

+0.011 (+0.08%)收盤時

Loading chart…
最高
13.260
開盤
13.250
成交量加權均價
13.25
成交量
2.33M
市值
472.93M
最低
13.240
成交金額
30.85M
企業價值/稅息折舊攤銷前利潤(TTM)
44.08

Cross Country Healthcare, Inc. is a healthcare workforce solutions company delivering an AI-powered digital platform and advisory services. The Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and allied professionals, and healthcare leaders within nursing, allied, physician, and human resources; vendor neutral programs and managed service programs; education healthcare services; caregiver services to PACE programs, and outsourcing services. The Physician Staffing segment provides physicians in many specialties, as well as certified registered nurse anesthetists, nurse practitioners, and physician assistants as independent contractors on temporary assignments throughout the United States at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations.

AI 分析 of Cross Country Healthcare Inc (CCRN)

持有

CCRN is not a good buy right now for a beginner long-term investor with $50,000-$100,000 who wants an immediate entry. The stock is essentially flat, technicals are mixed, there is no fresh news catalyst, analyst sentiment is not provided, and the proprietary trading signals show no buy setup today. I would not buy it now; I would hold off and wait for a clearer catalyst or stronger momentum.

分析師評級(8)

-27.09% 下跌空間
買進
6 買進
2 持有
0 賣出
目前: 13.25
最低
8.65
平均
9.66
最高
11.00

Wedbush

2026-03-19

目標價

$15

優於大盤

UBS

2026-03-06

目標價

$10

中性

Benchmark

2026-03-05

目標價

$14

買進

Wedbush

2026-02-03

目標價

$11

中性

Truist

2025-12-16

目標價

$10

持有

估值指標

Cross Country Healthcare Inc(CCRN)目前預期本益比為 126.58,5 年平均預期本益比為 37.13。

預期本益比

嚴重高估
5 年均值 P/E
37.13
目前P/E
126.58
高估
77.50
低估
-3.24

預期 EV/EBITDA

嚴重高估
5 年均值 EV/EBITDA
10.47
目前EV/EBITDA
44.08
高估
19.84
低估
1.10

預期股價營收比

合理
5 年均值 P/S
0.41
目前P/S
0.42
高估
0.50
低估
0.33

Alphio AI 對 CCRN 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%CCRN

$11.28

情境價格

基

基準

基準 · 50%CCRN

$10.05

情境價格

悲

悲觀

悲觀 · 25%CCRN

$9.35

情境價格

持有 CCRN 的大戶

M

Magnetar Capital Partners, LP

+ 持有CCRN

+3.27%

3個月報酬率

事件時間軸

2026-05-14 (ET)

07:40:00

Cross Country Healthcare Signs Exclusive 36-Month Partnership with Optime

2026-05-08 (ET)

08:30:00

Benchmark Downgrades Cross Country Healthcare to Hold

2026-05-07 (ET)

17:00:00

Company Reports Q1 Revenue of $241.06M, Exceeding Expectations

11:30:00

Citizens Analyst Downgrades Cross Country Healthcare to Market Perform

07:20:00

Wedbush Downgrades Cross Country Healthcare to Neutral, Price Target Cut to $13.25

資訊

CCRN 常見問題 —— 由 Alphio AI 解答

Cross Country Healthcare, Inc. is a healthcare workforce solutions company delivering an AI-powered digital platform and advisory services. The Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and allied professionals, and healthcare leaders within nursing, allied, physician, and human resources; vendor neutral programs and managed service programs; education healthcare services; caregiver services to PACE programs, and outsourcing services. The Physician Staffing segment provides physicians in many specialties, as well as certified registered nurse anesthetists, nurse practitioners, and physician assistants as independent contractors on temporary assignments throughout the United States at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. It operates in the Industrials sector (SERVICES-HELP SUPPLY SERVICES industry).

CCRN is not a good buy right now for a beginner long-term investor with $50,000-$100,000 who wants an immediate entry. The stock is essentially flat, technicals are mixed, there is no fresh news catalyst, analyst sentiment is not provided, and the proprietary trading signals show no buy setup today. I would not buy it now; I would hold off and wait for a clearer catalyst or stronger momentum.

8 analysts cover CCRN: 6 rate it Buy, 2 Hold and 0 Sell. The average price target is 9.66.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易